DeepMed Research

Instituto Mexicano del Seguro Social

🇲🇽Mexico

Country: 🇲🇽Mexico

Ownership: Private

Established: 1943-01-01

Employees: 10K

Market Cap: -

Website: http://www.imss.gob.mx

Clinical Trials

PRIMARY TESTICULAR LYMPHOMA

Completed

Conditions: Testicular Lymphoma

First Posted Date: 2025-05-09

Last Posted Date: 2025-05-09

Lead Sponsor: Instituto Mexicano del Seguro Social

Target Recruit Count: 1

Registration Number: NCT06964841

Locations: 🇲🇽
Instituto Mexicano del Seguro Social, Mérida, Yucatán, Mexico

Adrenal Myelolipomas Case Series

Completed

Conditions: Adrenal Myelolipoma

First Posted Date: 2025-04-06

Last Posted Date: 2025-04-06

Lead Sponsor: Instituto Mexicano del Seguro Social

Target Recruit Count: 6

Registration Number: NCT06913842

Locations: 🇲🇽
Mexican Social Security Institute: Regional General Hospital No. 1, Mérida, Estado De Yucatán, Mexico

Telerehabilitation in Patients With Ankle Fracture

Not Applicable

Recruiting

Conditions: Ankle Fracture

First Posted Date: 2025-02-06

Last Posted Date: 2025-04-24

Lead Sponsor: Instituto Mexicano del Seguro Social

Target Recruit Count: 172

Registration Number: NCT06811090

Locations: 🇲🇽
Unidad Médica de Alta Especialidad (UMAE) de Traumatología, Ortopedia y Rehabilitación "Dr. Victorio de la Fuente Narváez",, Mexico, Gustavo A Madero, Mexico

Early Botulinum Toxin for Muscle Stiffness Reduction in First-Time Stroke Patients: Improving Recovery and Independence

Early Phase 1

Active, not recruiting

Conditions: Spasticity
Stroke
Neurological Rehabilitation

Interventions: Drug: Botulinum Toxin Type A (BoNT-A)

First Posted Date: 2025-02-06

Last Posted Date: 2025-02-10

Lead Sponsor: Instituto Mexicano del Seguro Social

Target Recruit Count: 200

Registration Number: NCT06811142

Locations: 🇲🇽
Hospital General Regional No.1 "Lic. Ignacio García Téllez" IMSS, Calle 41 101, Fénix, 97155 Mérida, Yuc., Merida, Yucatán, Mexico

Anatomical Scale for the Prognosis of Fournier Syndrome.

Phase 3

Completed

Conditions: Fournier's Gangrene

First Posted Date: 2025-02-05

Last Posted Date: 2025-02-05

Lead Sponsor: Instituto Mexicano del Seguro Social

Target Recruit Count: 58

Registration Number: NCT06809738

Locations: 🇲🇽
Mexican Social Security Institute: Regional General Hospital No. 1, Mérida, Estado de Yucatán, Mexico

Clinical Effects of Incobotulinum Toxin vs Corticosteroid in Plantar Fascitis

Phase 1

Active, not recruiting

Conditions: Plantar Fasciitis of Both Feet
Pain
Function

Interventions: Drug: Incobotulinum Toxin A
Drug: Glucocorticoid

First Posted Date: 2025-01-23

Last Posted Date: 2025-01-23

Lead Sponsor: Instituto Mexicano del Seguro Social

Target Recruit Count: 20

Registration Number: NCT06788158

Locations: 🇲🇽
Hospital General Regional No.1 "Lic. Ignacio García Téllez" IMSS, Calle 41 101, Fénix, 97155 Mérida, Yuc., Mérida, Yucatán, Mexico

Effect of Dolutegravir Compared with Darunavir/Cobicistat on the Severity of Neuropsychiatric Effects Al 12 Weeks in Antirretroviral Treatment-Naive Adults.

Phase 4

Not yet recruiting

Conditions: HIV
Insomnia
Anxiety

Interventions: Drug: Dolutegravir (DTG)
Drug: Darunavir/Cobicistat (FDC)

First Posted Date: 2025-01-22

Last Posted Date: 2025-01-22

Lead Sponsor: Instituto Mexicano del Seguro Social

Target Recruit Count: 140

Registration Number: NCT06787976

Effect of Subcutaneous Polyvidone Collagen Treatment on Hand Recovery in Adult Rheumatoid Arthritis.

Phase 1

Completed

Conditions: Arthritis, Rheumatoid

Interventions: Drug: Subcutaneous polyvidone collagen
Other: saline solution

First Posted Date: 2024-10-24

Last Posted Date: 2025-05-01

Lead Sponsor: Instituto Mexicano del Seguro Social

Target Recruit Count: 25

Registration Number: NCT06656169

Locations: 🇲🇽
National Western Speciality Hospital, Mexican Social Security Institute, Guadalajara, Jalisco, Mexico
🇲🇽
Unidad de Investigación Biomédica 02, Unidad Médica de alta especialidad, Hospital de Especialidades Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara 44329, México, Guadalajara, Jalisco, Mexico

Pilot Study on the Efficacy of Two Intraperitoneal Ondansetron Formulations for Postoperative Pain Management After Laparoscopic Choleycstectomy.

Phase 4

Not yet recruiting

Conditions: Ondansetron
Postoperative Pain Management
Laparoscopic Cholecystectomy
Postoperative Nausea and Vomiting

Interventions: Drug: Ondansetron (ODT) + Saline Solution
Drug: Ondansetron (ODT) + Bicarbnate solution

First Posted Date: 2024-10-08

Last Posted Date: 2024-11-12

Lead Sponsor: Instituto Mexicano del Seguro Social

Target Recruit Count: 20

Registration Number: NCT06632184

Locations: 🇲🇽
Hospital General de Zona No. 21, Instituto Mexicano del Seguro Social (IMSS), Tepatitlan, Jalisco, Mexico

Incidence of Metabolic Syndrome in People Living With HIV Without ExperienCe to ART Who Start DoLutegravir Based-Regimen Compared With BictegrAvir Based-RegimeN

Not Applicable

Completed

Conditions: Antiretroviral Treatment
HIV Infection
Metabolic Cardiovascular Syndrome

Interventions: Drug: Bictegravir

First Posted Date: 2024-10-07

Last Posted Date: 2024-10-07

Lead Sponsor: Instituto Mexicano del Seguro Social

Target Recruit Count: 378

Registration Number: NCT06629480

Locations: 🇲🇽
Hospital de Infectología, "La Raza" National Medical Center, Mexico City, Mexico

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy